title: Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
authors.affiliation: Department of Surgery, University of Minnesota, Minneapolis.
authors.forename: C
authors.initials: C
authors.lastname: Troppmann
authors.forename: P S
authors.initials: PS
authors.lastname: Almond
authors.forename: W D
authors.initials: WD
authors.lastname: Payne
authors.forename: D L
authors.initials: DL
authors.lastname: Dunn
authors.forename: P F
authors.initials: PF
authors.lastname: Gores
authors.forename: R W
authors.initials: RW
authors.lastname: Gruessner
authors.forename: D E
authors.initials: DE
authors.lastname: Sutherland
authors.forename: A J
authors.initials: AJ
authors.lastname: Matas
authors.forename: J S
authors.initials: JS
authors.lastname: Najarian
mesh_terms: D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000503:physiopathology* / Q000628:therapy; D006085:Graft Survival / Q000276:immunology / Q000502:physiology*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D007683:Kidney Tubular Necrosis, Acute / Q000503:physiopathology*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone